Martek Biosciences Corporation (MATK)

SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Steve Dubin , CEO/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Steve Dubin, CEO/Director

6480 Dobbin Road

Columbia, MD 21045

US Map it

Phone: (410) 740-0081

Fax: (410) 740-2985

www.martekbio.com



Overview

The Company develops omega-3 DHA products that promote health and wellness through every stage of life.

News From Around the Web
News
powered by  inform

Employees

Number of Employees: 515
Revenue per Employee: $595,753

Financials

Quarterly
Annual

Income Statement 09/2008 06/2008 03/2008 12/2007
Sales 53.63 Mil. 55.22 Mil. 50.46 Mil. 48.38 Mil.
Gross Operating Profit 34.78 Mil. 35.51 Mil. 32.42 Mil. 33.64 Mil.
Operating Income before D & A (EBITDA) 14.6 Mil. 14.36 Mil. 13.3 Mil. 19.33 Mil.
Total Income Before Interest Expenses (EBIT) 14.94 Mil. 14.67 Mil. 13.52 Mil. 12.36 Mil.
Total Net Income 9.33 Mil. 9.2 Mil. 8.67 Mil. 18.27 Mil.
Basic EPS, Total 0.28 0.28 0.26 0.56
Diluted EPS, Total 0.28 0.28 0.26 0.56

BALANCE STATEMENT 09/2008 06/2008 03/2008 12/2007
Cash and Equivalents 57.62 Mil. 44.66 Mil. 22.14 Mil. 16.97 Mil.
Total Assets NA NA NA 195.49 Mil.
Total Liabilities 41.76 Mil. 43.22 Mil. 37.39 Mil. 46.14 Mil.
Total Capitalization 630.18 Mil. 566.45 Mil. 555.16 Mil. 541.04 Mil.

Cash Flow 09/2008 06/2008 03/2008 12/2007
Net Cash From Continuing Operations 61.94 Mil. 38.76 Mil. 15.12 Mil. 45.86 Mil.
Net Cash From Investing Activities -19.64 Mil. -16.59 Mil. -13.82 Mil. -10.72 Mil.
Net Cash From Financing Activities -1.64 Mil. 5.52 Mil. 3.87 Mil. -33.74 Mil.
Net Change in Cash & Cash Equivalents 40.65 Mil. 27.68 Mil. 5.17 Mil. 1.4 Mil.

powered by Interactive Data

Income Statement 2007 2006 2006 2005
Sales 173.41 Mil. 151.6 Mil. 116.89 Mil. 106.31 Mil.
Gross Operating Profit 133.4 Mil. 119.05 Mil. 100.96 Mil. 78.19 Mil.
Operating Income before D & A (EBITDA) 62.08 Mil. 51.46 Mil. 39.44 Mil. 29.82 Mil.
Total Income Before Interest Expenses (EBIT) 35.9 Mil. 31.07 Mil. 24.37 Mil. 21.9 Mil.
Total Net Income 32.01 Mil. 17.81 Mil. 15.28 Mil. 47.05 Mil.
Basic EPS, Total 0.99 0.55 0.49 1.62
Diluted EPS, Total 0.98 0.55 0.48 1.55

BALANCE STATEMENT 2007 2006 2006 2005
Cash and Equivalents 16.97 Mil. 15.58 Mil. 11.05 Mil. 29.44 Mil.
Total Assets 195.49 Mil. 169.97 Mil. 158.41 Mil. 117.11 Mil.
Total Liabilities 46.14 Mil. 49.79 Mil. 34.21 Mil. 48.92 Mil.
Total Capitalization 541.04 Mil. 541.72 Mil. 535.32 Mil. 443.34 Mil.

Cash Flow 2007 2006 2006 2005
Net Cash From Continuing Operations 45.86 Mil. 35.62 Mil. -17.14 Mil. 10.09 Mil.
Net Cash From Investing Activities -10.72 Mil. -13.59 Mil. -66.99 Mil. -125.06 Mil.
Net Cash From Financing Activities -33.74 Mil. -17.5 Mil. 65.74 Mil. 114.49 Mil.
Net Change in Cash & Cash Equivalents 1.4 Mil. 4.53 Mil. -18.4 Mil. -479 K.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
952.85 Mil.
920.55 Mil.
1.11 Bil.
1.14 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented

Newsletter Sign-Up
Subscribe
Newsletter Sign-Up
Subscribe